Liver Matters: Early Detection and Diagnosis of SLD
Free
- Length
- 1 hr
- Platform
- Zoom
- Topic
- Medical & Clinical
About this webinar
This EASL Liver Matters webinar explores early detection and diagnosis of steatotic liver disease (SLD), with a focus on MetALD in primary care. Experts will discuss risk identification, non-invasive assessment, specialist referral, non-stigmatising patient communication, and collaboration between primary and secondary care to improve patient management.
Learning objectives:
1) Recognise patients at increased risk of MetALD and opportunities for earlier detection in primary care.
2) Describe approaches to the initial assessment and diagnosis of suspected MetALD, including the use and limitations of non-invasive tools.
3) Identify when patients with suspected or established MetALD should be referred to specialist hepatology care.
4) Apply non-stigmatising communication strategies when discussing alcohol use, metabolic risk factors, and liver health.
5) Explain how primary and secondary care can collaborate to improve referral, follow-up, and shared management of MetALD.
This Liver Matters Webinar is planned as follows:
- Presentation of a case study
- Primary care and patient perspectives
- Expert discussion
- Q&A
- Key takeaways and conclusion
Participants are eligible to receive 0.5 CME credit for each 30-minute time slot attended, with credit eligibility beginning after the initial 30 minutes of live participation. CME certificates will be issued to participants who attend the live session and complete the feedback form.
Register now and join the live discussion!
We thank our healthcare industry partners, Gilead Sciences Inc., GSK plc and Novo Nordisk for their support of the ‘Liver Matters Series’ EASL and its Policy, Public Health Department retain full ownership of and complete independence over the programme. Our partners have had no role in the design, development, or control of the programme content.